SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-024786
Filing Date
2024-02-06
Accepted
2024-02-06 07:10:02
Documents
17
Period of Report
2024-02-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d128290d8k.htm   iXBRL 8-K 24722
2 EX-99.1 d128290dex991.htm EX-99.1 90581
6 GRAPHIC g128290dsp1.jpg GRAPHIC 4373
7 GRAPHIC g128290g0206005714408.jpg GRAPHIC 3142
  Complete submission text file 0001193125-24-024786.txt   256707

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dcph-20240206.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dcph-20240206_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dcph-20240206_pre.xml EX-101.PRE 10816
18 EXTRACTED XBRL INSTANCE DOCUMENT d128290d8k_htm.xml XML 3494
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 24598074
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)